Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

New Study Shows Cinnamon Lowers Blood Sugar Levels In Type 2’s Posted: Friday, July 14, 2006

A water-soluble, cinnamon extract has been shown to reduce fasting blood sugar levels in patients with type 2 diabetes, according to a new study from the University of Hannover in Hannover, Germany.

Evening and Bedtime Second Dose Equal for Long-Acting Insulin Levemir Posted: Friday, July 14, 2006

Patients who take Levemir (insulin detemir) twice daily can chose a convenient evening time for their second dose.

Acetaminophen Study Sparks Concern Over 4 Gram Dosage Posted: Friday, July 14, 2006

New research shows signs of liver damage, but even the co-authors differ about what their findings mean for regular users.

Exenatide Reduces Insulin Use in Type 2 Diabetics Posted: Friday, July 07, 2006

Exenatide therapy results in weight loss and a substantial decrease in insulin doses in some of the most difficult-to-manage patients with type 2 diabetes.

Investigational Drug Produces Significant Weight Loss for Obese Posted: Friday, July 07, 2006

Investigators reported that — Lorcaserin, an investigational drug for the treatment of obesity, produced weight losses between four and 7.9 pounds (1.8 to 3.6 kg) in a 12-week phase IIb dose-ranging study.

Metformin Induces Long-Term Weight Loss in Teens Posted: Friday, July 07, 2006

Metformin can induce long-term weight loss in obese, non-diabetic adolescents, and could possibly be useful in a regimen to help achieve weight loss in adolescents, who may have developed type 2 diabetes type due to overweight.

Sanofi's Acomplia (rimonabant) Weight Loss Drug Gets EU Approval Posted: Friday, July 07, 2006

The European Commission has approved 20-mg tablets of rimonabant for use as an adjunct to diet and exercise in the treatment of obese or overweight patients with associated cardiometabolic risk factors such as type 2 diabetes or dyslipidemia.

LDL Cholesterol Below Recommended Levels Is Better Posted: Friday, June 30, 2006

Lowering LDL ("bad") cholesterol levels substantially below currently recommended levels significantly reduces the chances that people with diabetes and heart disease will suffer a stroke or heart attack, researchers report.

Statins Prevent Cataracts, Also? Posted: Friday, June 30, 2006

People taking statins to lower their cholesterol may reap another reward. A new study shows the drugs may also reduce the risk for the most common type of cataract by 60%.

Type 2 Diabetics Who Use Insulin at Increased Risk for Hypertension Posted: Friday, June 30, 2006

The hypertension risk increased with the duration of insulin use; the odds ratio was 1.35 in diabetics who used insulin for 5 to 9 years and 1.46 in those who used insulin for 10 years or more.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.